70
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Pre/Post-Treatment Dynamic of Inflammatory Markers Has Prognostic Value in Patients with Small Hepatocellular Carcinoma Managed by Stereotactic Body Radiation Therapy

, , , , , , ORCID Icon & ORCID Icon show all
Pages 10929-10937 | Published online: 03 Jan 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chih-Weim Hsiang, Wen-Yen Huang, Jen-Fu Yang, Po-Chien Shen, Yang-Hong Dai, Ying-Fu Wang, Chun-Shu Lin, Wei-Chou Chang & Cheng-Hsiang Lo. (2021) Dynamic Changes in Neutrophil-to-Lymphocyte Ratio are Associated with Survival and Liver Toxicity Following Stereotactic Body Radiotherapy for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 8, pages 1299-1309.
Read now

Articles from other publishers (10)

Yuxin DuanHua ZhangTao TanWentao YeKunli YinYanxi YuMeiqing KangJian YangRui Liao. (2023) The immune response of hepatocellular carcinoma after locoregional and systemic therapies: The available combination option for immunotherapy. BioScience Trends 17:6, pages 427-444.
Crossref
Yoon Kyoung So, Zero Kim, Taek Yoon Cheong, Myung Jin Chung, Chung-Hwan Baek, Young-Ik Son, Jungirl Seok, Yuh-Seog Jung, Myung-Ju Ahn, Yong Chan Ahn, Dongryul Oh, Baek Hwan Cho & Man Ki Chung. (2023) Detection of Cancer Recurrence Using Systemic Inflammatory Markers and Machine Learning after Concurrent Chemoradiotherapy for Head and Neck Cancers. Cancers 15:14, pages 3540.
Crossref
Jingyao Chen, Wenhan Huang, Xiaohong Xu, Shaonan Fan, Qi Zhang, Xuan Li, Zhaochong Zeng & Jian He. (2023) Prognostic implications of systemic immune-inflammation index in patients with bone metastases from hepatocellular carcinoma treated with radiotherapy. Frontiers in Oncology 13.
Crossref
Ji Min Yun, Man Ki Chung, Chung Hwan Baek, Young Ik Son, Myung Ju Ahn, Dongryul Oh, Ki Won Kim & Yoon Kyoung So. (2023) Prognostic Significance of the Post-Treatment Neutrophil-to-Lymphocyte Ratio in Pharyngeal Cancers Treated with Concurrent Chemoradiotherapy. Cancers 15:4, pages 1248.
Crossref
Jian-Xu Li, Mei-Ling He, Mo-Qin Qiu, Liu-Ying Yan, Mei-Ying Long, Jian-Hong Zhong, Rui-Jun Zhang, Chun-Feng Liang, Ya-Dan Pang, Jun-Kun He, Qian-Qian Chen, Jin-Xia Weng, Shi-Xiong Liang & Bang-De Xiang. (2022) Prognostic value of a nomogram based on peripheral blood immune parameters in unresectable hepatocellular carcinoma after intensity-modulated radiotherapy. BMC Gastroenterology 22:1.
Crossref
Sarah Sabrina Zakaria, Anand Ramanathan, Zakiah Mat Ripen, Wan Maria Nabillah Ghani, Yi-Hsin Yang, Vui King Vincent-Chong & Siti Mazlipah Ismail. (2022) Prognostic Abilities of Pre- and Post-Treatment Inflammatory Markers in Oral Squamous Cell Carcinoma: Stepwise Modelling. Medicina 58:10, pages 1426.
Crossref
Younghee Park & Ah Ram Chang. (2022) Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in Hepatocellular Carcinoma Treated with Stereotactic Body Radiotherapy. The Korean Journal of Gastroenterology 79:6, pages 252-259.
Crossref
Bong Kyung Bae, Hee Chul Park, Gyu Sang Yoo, Moon Seok Choi, Joo Hyun Oh & Jeong Il Yu. (2022) The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment. Cancers 14:9, pages 2081.
Crossref
Yipin Yu, Duoting Tan, Can Liao, Pei Yang, Zhixi Hu & Hao Liang. (2022) Neutrophil‑to‑lymphocyte ratio as a prognostic predictor for patients with cancer treated with stereotactic body radiation therapy: A meta‑analysis. Molecular and Clinical Oncology 16:5.
Crossref
Shuai Liang, Chengming Li, Zhenhua Gao, Jianing Li, Heng Zhao, Jinming Yu & Xue Meng. (2021) A nomogram to predict short-term outcome of radiotherapy or chemoradiotherapy based on pre/post-treatment inflammatory biomarkers and their dynamic changes in esophageal squamous cell carcinoma. International Immunopharmacology 90, pages 107178.
Crossref